Skip to main content
Caplight Logo









Koite Health

Koite Health

Private
EspooHealthcare & Life Scienceshttps://koitehealth.com/

Last Round

Early Funding

Feb 17, 2025

Total Funding Raised

$2.37M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Koite Health is a health technology company that develops and commercializes light-activated antibacterial therapies, including its flagship Lumoral product for oral care.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, D2C Brands, Subscription Commerce, Clinical Trials

Business Model

B2C

Customer Profile

Hardware Sales, Subscription SaaS

AI Layer

Non-AI

Keywords

photodynamic therapyoral healthantibacterial treatmentlight therapymedical deviceat-home dentistryoral biofilmhome-use medical devicebiofilm managementperiodontitis treatmentphotobiomodulationrazor and bladesoral mucositissubscription commerceteledentistry

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Koite Health Comparables

Compare Koite Health with similar companies based on industry and business-model similarity.

Koite Health comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
PhotoDynamic Inc.
88%
Oralucent
77%
Bristl Science
73%

Koite Health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingFeb 17, 2025
VC RoundDec 1, 2023
VC RoundDec 21, 2021
SeedDec 1, 2020

Key People

Founding team and executive leadership

Sakari Nikinmaa

Co-Founder, CTO

Founding Team

Peter Radqvist

CEO

Executive Team

Koite Health Investors

Notable investors and investment history

Koite Health investors
InvestorRounds
8 Media VenturesVC Round
Pharmacy Pension Fund of FinlandVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 333% MoM, reaching 2.2K.

  • Jan 19, 2026

    Monthly visitors increased 41% MoM.

Koite Health Filings

Explore SEC and related filing metadata, where available.

Koite Health filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Koite Health's valuation, stock price, and market status.

Is Koite Health a public or private company?

Koite Health is a private company.

What is the current stock price of Koite Health?

Koite Health is a private company with no public stock price. No recent secondary market data is available.

How much is Koite Health worth (valuation)?

Valuation information for Koite Health is not publicly available.

Can I buy Koite Health stock?

Koite Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Koite Health's last funding round?

Koite Health's most recent funding round was Early Funding on February 17, 2025.

Who are the main investors in Koite Health?

Key investors in Koite Health include 8 Media Ventures, Pharmacy Pension Fund of Finland.

Will Koite Health IPO soon?

No public IPO plans have been announced for Koite Health.

How can I track Koite Health secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Koite Health's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersEspoo
Employee Range11
Year Founded2018
Last FundingFeb 17, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?